Isturisa Tablet, Coated
Product Images NDC 55292-330

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isturisa (NDC 55292-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Isturisa (osilodrostat) Tablets, 1 mg Label (Image 01)

Isturisa (osilodrostat) Tablets, 1 mg Label (Image 01)
Packaging label for Isturisa 1 mg tablets (osilodrostat) manufactured by Novartis Pharma Stein AG and distributed by Recordati Rare Diseases, Inc. The label shows a 60-count bottle of film-coated tablets with usage and storage instructions. It includes branding, dosage strength, active ingredient, and contact information.*
FDA Label Image

Isturisa (osilodrostat) Tablets, 5 mg Label (Image 02)

Isturisa (osilodrostat) Tablets, 5 mg Label (Image 02)
Isturisa 5 mg (osilodrostat) tablets carton label from Recordati Rare Diseases, Inc. The label states the product is for oral use with 60 film-coated tablets per package. It includes storage instructions, manufacturer details (Novartis Pharma Stein AG, Switzerland), and a barcode. The label highlights the 5 mg strength and indicates prescription use only.*
FDA Label Image

Isturisa (osilodrostat) Tablets, 10 mg Label (Image 03)

Isturisa (osilodrostat) Tablets, 10 mg Label (Image 03)
Packaging label for Isturisa 10 mg tablets (osilodrostat) by Recordati Rare Diseases, Inc. The label indicates 60 film-coated tablets per package with storage instructions and a U.S. contact number for information. Manufactured by Novartis Pharma Stein AG.*
FDA Label Image

Recordati Rare Diseases Logo (Image 04)

FDA Label Image

Osilodrostat Structural Formula (Image 05)

Osilodrostat Structural Formula (Image 05)
Chemical structure of the active ingredient in Isturisa, showing a bicyclic compound with a fluorobenzene ring bearing a cyano group and a phosphate counterion (H2PO4-).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.